Matthew J. Kluko
A5005478268- Long-Term Effects of COVID-19
- Infant Development and Preterm Care
- Migraine and Headache Studies
- COVID-19 and Mental Health
- COVID-19 Clinical Research Studies
- Childhood Cancer Survivors' Quality of Life
- Thermal Regulation in Medicine
- Neurological Disorders and Treatments
- Infectious Encephalopathies and Encephalitis
- Cerebral Palsy and Movement Disorders
Yale University
2023-2024
Importance The prevalence, pathophysiology, and long-term outcomes of COVID-19 (post-acute sequelae SARS-CoV-2 [PASC] or “Long COVID”) in children young adults remain unknown. Studies must address the urgent need to define PASC, its mechanisms, potential treatment targets adults. Observations We describe protocol for Pediatric Observational Cohort Study NIH’s RE searching COV ID E nhance R ecovery (RECOVER) Initiative. RECOVER-Pediatrics is an observational meta-cohort study caregiver-child...
Abstract Importance The prevalence, pathophysiology, and long-term outcomes of COVID-19 (post-acute sequelae SARS-CoV-2 [PASC] or “Long COVID”) in children young adults remain unknown. Studies must address the urgent need to define PASC, its mechanisms, potential treatment targets adults. Observations We describe protocol for Pediatric Observational Cohort Study NIH’s RE searching COV ID E nhance R ecovery (RECOVER) Initiative. RECOVER-Pediatrics is an observational meta-cohort study...
<h3>Objective</h3> To evaluate the role of CGRP Antagonists in management Post-Concussion Headaches. <h3>Background</h3> Headaches are one most common, debilitating symptoms experienced post-concussion patients. Previous studies show these mediated through a dependent mechanism. Injectable monoclonal antibodies directed against have seen widespread use for migraines since their approval 2018, however there has been minimal evaluation effectiveness managing headaches. <h3>Design/Methods</h3>...